Regeneron Pharmaceuticals
Definition
Regeneron Pharmaceuticals Inc. is a leading American biotechnology company headquartered in Tarrytown, New York, specializing in the discovery, invention, development, manufacturing, and commercialization of life-changing medicines for people with serious diseases, including eye disorders, allergic and inflammatory diseases, cancer, and infectious diseases.
Renowned for blockbuster drugs like Eylea (for wet AMD), Dupixent (for eczema and asthma), and the COVID-19 monoclonal antibody cocktail REGEN-COV, Regeneron is a powerhouse in genetic engineering and antibody tech.
Examples
After a rough flu season, my hypochondriac uncle swore by Regeneron Pharmaceuticals' latest antiviral – now he's regenerating faster than a Marvel mutant.
Wall Street traders popped champagne when Regeneron Pharmaceuticals announced their earnings; their stock's the real wonder drug for insomnia-plagued investors.
Grandma ditched her knitting needles for CrossFit post-Regeneron Pharmaceuticals treatment – talk about a monoclonal glow-up.
In the biotech battlefield, Regeneron Pharmaceuticals is the sniper with antibodies that hit every target, leaving competitors reloaded with envy.